DKI can distinguish high-grade gliomas from IDH1-mutant low-grade gliomas and correlate with their different nuclear-to-cytoplasm ratio: a localized biopsy-based study.

MLA

Pang, Haopeng, et al. “DKI Can Distinguish High-Grade Gliomas from IDH1-Mutant Low-Grade Gliomas and Correlate with Their Different Nuclear-to-Cytoplasm Ratio: A Localized Biopsy-Based Study.” European Radiology, vol. 34, no. 11, Nov. 2024, pp. 7539–51. EBSCOhost, https://doi.org/10.1007/s00330-023-10325-8.

APA

Pang, H., Dang, X., Ren, Y., Yao, Z., Shen, Y., Feng, X., & Wang, Z. (2024). DKI can distinguish high-grade gliomas from IDH1-mutant low-grade gliomas and correlate with their different nuclear-to-cytoplasm ratio: a localized biopsy-based study. European Radiology, 34(11), 7539–7551. https://doi.org/10.1007/s00330-023-10325-8

Chicago

Pang, Haopeng, Xuefei Dang, Yan Ren, Zhenwei Yao, Yehua Shen, Xiaoyuan Feng, and Zhongmin Wang. 2024. “DKI Can Distinguish High-Grade Gliomas from IDH1-Mutant Low-Grade Gliomas and Correlate with Their Different Nuclear-to-Cytoplasm Ratio: A Localized Biopsy-Based Study.” European Radiology 34 (11): 7539–51. doi:10.1007/s00330-023-10325-8.